Tugal-Tutkun, I. Et Al. 2018. Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study. OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7 , 1023-1033.

Tugal-Tutkun, I., PAVESIO, C., DE CORDOUE, A., BERNARD-POENARU, O., & Gül, A., (2018). Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study. OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, 1023-1033.

Tugal-Tutkun, Ilknur Et Al. "Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study," OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, 1023-1033, 2018

Tugal-Tutkun, Ilknur Et Al. "Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study." OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, pp.1023-1033, 2018

Tugal-Tutkun, I. Et Al. (2018) . "Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study." OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, pp.1023-1033.

@article{article, author={Ilknur Tugal-Tutkun Et Al. }, title={Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study}, journal={OCULAR IMMUNOLOGY AND INFLAMMATION}, year=2018, pages={1023-1033} }